Cochlear Limited (ASX: COH)

2012
7 Feb: F'12 half year results | Financial statements
7 Feb: Update on Nucleus CI500 series implant voluntary recall

2011
20 Dec:  Update on Nucleus CI500 Series Implant Recall
18 Oct:  Chairman's AGM address to shareholders
26 Sep: Letter to Shareholders
11 Sep: Cochlear announces voluntary recall of Nucleus CI500 cochlear implant range
9 Aug: F'11 full year results | Financial statements
14 Mar: F'11 half year report
8 Feb: F'11 half year results | Financial statements

2010
19 Oct: Chairman's AGM address to shareholders
10 Aug:  F'10 full year results |  Financial statements
2 Aug: Cochlear Announces Appointment of Non-executive Director
4 June: Settlement agreement with DOJ and OIG
17 Mar: Cochlear Ltd Announces Appointment of New Chairman
15 Mar: F'10 half year report
9 Feb: F'10 half year results | Financial statements

2009
20 Oct: Chairman's AGM address to shareholders
09 Sep: Technology purchase: towards a totally implantable cochlear implant
04 Sep: FDA approval for Nucleus 5 system
11 Aug: F'09 full year results | Financial statements
14 July: Cochlear market update
04 Jun: Cochlear completes debt refinancing
03 Jun: Conclusion of agreements for new global headquarters
16 Mar: F'09 half year report
10 Feb: F'09 half year results | Financial statements

2008
21 Oct: Chairman's AGM address to shareholders
12 Aug: F'08 full year results | Financial statements
17 Mar: F'08 half year report
22 Feb: FDA warning letter
12 Feb: F'08 half year results | Financial statements

2007
21 Dec: Cochlear to vigorously defend patent infringement complaint
23 Oct: Chairman's AGM address to shareholders
23 Oct: Cochlear's plans for new sydney global headquarters
14 Aug: F'07 full year results | Financial statements
13 Feb: F'07 half year results | Financial statements

2006
19 Dec: Cochlear acquires key supplier's operations
15 Dec: Appointment of director: Mr Andrew Denver
24 Oct: Chairman's AGM address to shareholders
15 Aug: F'06 full year results | Financial statements
17 July: Cochlear board changes
05 May: Cochlear announces approximately $270m order for China
10 Feb: Cochlear limited response to share price increase
14 Feb: Cochlear F'06 half year results | Financial statements

2005
14 Dec: F'06 full year earnings upgrade
20 Oct: Chairman's AGM address to shareholders
20 Oct: AGM shareholder questions & answers
16 Aug: F'05 full year results | Financial statements
21 July: Board changes
04 Mar: Entific acquisition
15 Feb: F'05 half year results | Financial statements
15 Feb: Appointment of director- Rick Holliday-Smith

2004
19 Oct: Shareholder questions and answers
17 Aug: F'04 full year results | Financial statements
27 Apr: CEO update
11 Mar: Request for information from US Dept of Justice
17 Feb: F'04 first half-year results | Financial statements

2003
14 Aug: F'03 full year financial statements